Protagenic Therapeutics Inc

NASDAQ:PTIX   4:00:00 PM EDT
3.43
+0.04 (+1.18%)
: $3.51 +0.08 (+2.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Protagenic Therapeutics Inc Stock, NASDAQ:PTIX

149 Fifth Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8200
Number of Employees: 3

Description

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.